Prevalence of SARS-CoV-2 infection among several populations of primary healthcare workers in comparison to the prediction in the general population and associated factors in France

Author:

Pouquet Marie1,Decarreaux Dorine2,Domenico Laura Di1,Sabbatini Chiara E.1,Prévot-Monsacre Pol1,Fourié Toscane3,Villarroel Paola Mariela Saba3,Priet Stephane3,Blanché Hélène4,Sebaoun Jean-Marc4,Deleuze Jean-François4,Turbelin Clément1,Rossignol Louise1,Werner Andréas5,Kochert Fabienne5,Grosgogeat Brigitte6,Rabiega Pascaline7,Laupie Julien8,Abraham Nathalie7,Noël Harold9,Werf Sylvie van der10,Colizza Vittoria1,Carrat Fabrice1,Charrel Remi3,de Lamballerie Xavier3,Blanchon Thierry1,Falchi Alessandra2

Affiliation:

1. Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, (IPLESP)

2. Université de Corse Pascal Paoli

3. Aix Marseille University, INSERM U1207

4. Fondation Jean Dausset-CEPH

5. Association Française de Pédiatrie Ambulatoire

6. Université Claude Bernard Lyon 1, Université de Lyon

7. IQVIA

8. Réseau ReCOL, Association Dentaire Française

9. Santé publique France

10. Institut Pasteur, Université Paris Cité, CNRS UMR3569

Abstract

Abstract Background Data on the SARS-CoV-2 infection among primary health care workers (PHCWs) are scarce but essential to reflect on policy regarding prevention and control measures. Aim We assessed the prevalence of PHCWs who have been infected by SARS-CoV-2 in comparison with modeling from the general population in metropolitan France, and associated factors. Methods A cross-sectional study was conducted among general practitioners (GPs), pediatricians, dental and pharmacy workers in primary care between May-August 2021. Participants volunteered to provide a dried-blood spot for SARS-CoV-2 antibody assessment and completed a questionnaire. The primary outcome was defined as the detection of infection-induced antibodies or previous self-reported diagnoses. Estimates were adjusted using weights for representativeness and compared with prediction from the general population. Poisson regressions were used to quantify associated factors. Results The analysis included 1612 PHCWs. Weighted prevalences were: 31.7% (95%CI: 27.5-36.0) for GPs, 28.7% (95%CI: 24.4-33.0) for pediatricians, 25.2% (95%CI: 20.6-31.0) for dentists, and 25.5% (95%CI: 18.2-34.0) for pharmacists. Estimates were compatible with model predictions for the general population. PHCWs more likely to be infected were: GPs compared to pharmacist assistants (adjusted prevalence ratio [aPR] = 2.26; CI95% 1.01-5.07), those living in Île-de-France (aPR= 1.53; CI95% 1.14-2.05), South-East (aPR = 1.57; CI95% 1.19-2.08), North-East (aPR= 1.81; CI95% 1.38-2.37), and those having an unprotected contact with a COVID-19 case within the household (aPR = 1.48; CI95% 1.22-1.80). Occupational factors were not associated with infection. Conclusion Results suggest that prevention practices implemented in primary care in France were effective, but should be strengthened when a case is detected at home.

Publisher

Research Square Platform LLC

Reference30 articles.

1. World Health Organization. The impact of COVID-19 on health and care workers: a closer look at deaths. Health Workforce Department – Working Paper 1. Geneva: World Health Organization; September 2021 (WHO/HWF/WorkingPaper/2021.1). Licence: CC BY-NC-SA 3.0 IGO 2021

2. The Lancet. COVID-19: protecting health-care workers. The Lancet. 2020;395(10228):922.10.1016/S0140-6736(20)30644-9

3. Galanis P, Vraka I, Fragkou D, Bilali A, Kaitelidou D. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. J Hosp Infect. 2021;108:120 – 34.10.1016/j.jhin.2020.11.008

4. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis;Kayı İ;Clinical Microbiology and Infection,2021

5. Chen X, Chen Z, Azman AS, Deng X, Sun R, Zhao Z, et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. The Lancet Global Health. 2021;9(5):e598-e609.10.1016/S2214-109X(21)00026 – 7

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3